On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

German Breast Group

InstitutionResearch output, impact & collaborations

German Breast Group is a institution indexed in ScholarIQ from OpenAlex.

What is known about German Breast Group?

ScholarIQrecord summary

German Breast Group is a research organisation in Offenbach, DE. OpenAlex records 1,355 works and 275,083 citations for it. 173 researchers list it as their most recent affiliation.

How many works does German Breast Group have?

ScholarIQindexed works

German Breast Group has 1,355 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does German Breast Group have?

ScholarIQcitation count

German Breast Group has 275,083 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at German Breast Group?

ScholarIQresearcher count

German Breast Group has 173 researchers in the ScholarIQ index.

What is the average h-index at German Breast Group?

ScholarIQavg h-index

German Breast Group has an average h-index of 85 in OpenAlex.

What is the ROR of German Breast Group?

ScholarIQror

The ROR for German Breast Group is on the source record.

What is the OpenAlex record for German Breast Group?

ScholarIQopenalex

The OpenAlex for German Breast Group is on the source record.

Who are the most-cited researchers behind German Breast Group?

ScholarIQtop researchers by citations
1
Gϋnter von Minckwitz · Breast Cancer Treatment Studies
865 works63,182 citations
2
Valentina Nekljudova · Breast Cancer Treatment Studies
459 works17,967 citations

What are the most-cited papers on German Breast Group?

ScholarIQmost cited works
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P. Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa, Sandra M. Swain, Tatiana M. Prowell, Sibylle Loibl, D. Lawrence Wickerham, Jan Bogaerts, José Baselga, Charles M. Perou, Gideon M. Blumenthal, Jens‐Uwe Blohmer, Eleftherios P. Mamounas, Jonas Bergh, Semiglazov Vf, Robert Justice, Holger Eidtmann, Soonmyung Paik, Martine Piccart, Rajeshwari Sridhara, Peter A. Fasching, Leen Slaets, Shenghui Tang, Bernd Gerber, Charles E. Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, W. Eiermann, Gϋnter von Minckwitz
The Lancet. 20144,765 CitationsOPEN ACCESS
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, Miguel Martín, Michael F. Press, John R. Mackey, John A. Glaspy, Arlene Chan, Marek Pawlicki, Tamás Pintér, Vicente Valero, Mei-Ching Liu, Guido Sauter, Gϋnter von Minckwitz, F. Visco, Valerie Bée, Marc Buyse, Belguendouz Bendahmane, Isabelle Tabah-Fisch, Mary-Ann Lindsay, A. Riva, John Crown
New England Journal of Medicine. 20112,784 CitationsOPEN ACCESS
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gϋnter von Minckwitz, Michael Untch, Jens‐Uwe Blohmer, Serban Dan Costa, Holger Eidtmann, Peter A. Fasching, Bernd Gerber, W. Eiermann, J. Hilfrich, Jens Huober, Christian Jackisch, Manfred Kaufmann, Gottfried E. Konecny, Carsten Denkert, Valentina Nekljudova, Keyur Mehta, Sibylle Loibl
Journal of Clinical Oncology. 20122,692 Citations
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
Gϋnter von Minckwitz, Chiun‐Sheng Huang, Max S. Mano, Sibylle Loibl, Eleftherios P. Mamounas, Michael Untch, Norman Wolmark, Priya Rastogi, Andreas Schneeweiß, Andrés Redondo, Hans Holger Fischer, William Jacot, Alison Conlin, Claudia Arce-Salinas, Irene Wapnir, Christian Jackisch, Michael P. DiGiovanna, Peter A. Fasching, John Crown, P Wülfing, Zhimin Shao, Elena Rota Caremoli, Haiyan Wu, Lisa H. Lam, David Tesarowski, Melanie C. Smitt, Hannah Douthwaite, Stina Mui Singel, Charles E. Geyer
New England Journal of Medicine. 20182,652 CitationsOPEN ACCESS
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert, Gϋnter von Minckwitz, Silvia Darb‐Esfahani, Bianca Lederer, Barbara Ingold Heppner, Karsten E. Weber, Jan Budczies, Jens Huober, Frederick Klauschen, Jenny Furlanetto, Wolfgang Schmitt, Jens‐Uwe Blohmer, Thomas Karn, Berit M. Pfitzner, Sherko Kümmel, Knut Engels, Andreas Schneeweiß, Arndt Hartmann, Aurelia Noske, Peter A. Fasching, Christian Jackisch, Marion van Mackelenbergh, Hans‐Peter Sinn, Christian Schem, Claus Hanusch, Michael Untch, Sibylle Loibl
The Lancet Oncology. 20172,153 Citations

How much of the research on German Breast Group is open access?

ScholarIQopen access share
50%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
0%
Bronze
33%
Closed
50%

Related on ScholarIQ

470M+ articles · 14-day free trial